All contributors
Onconephrology contributor
Dimopoulos, Meletios A
Primarily Myeloma cast nephropathy#4 of 47 recognizedHonor roll
- #2 in Myeloma cast nephropathy
95
Clinical papers
9,560
Citations (iCite)
24 / 38
First / senior author
2002–2026
Active years
Output over time
Clinical corpus papers per year — peak 11 in 2016.
- 2002: 1 paper
- 2004: 1 paper
- 2006: 1 paper
- 2007: 2 papers
- 2008: 2 papers
- 2009: 4 papers
- 2010: 7 papers
- 2011: 4 papers
- 2012: 5 papers
- 2013: 4 papers
- 2014: 5 papers
- 2015: 2 papers
- 2016: 11 papers
- 2017: 3 papers
- 2018: 4 papers
- 2019: 3 papers
- 2020: 8 papers
- 2021: 7 papers
- 2022: 4 papers
- 2023: 2 papers
- 2024: 3 papers
- 2025: 7 papers
- 2026: 5 papers
20022026
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
Myeloma cast nephropathy84
MGRS & paraprotein kidney disease25
Cellular therapy renal effects2
Frequent collaborators
Other recognized contributors who most often share corpus papers with Dimopoulos (shared-paper count).
Agents they study
Catalog agents whose clinical kidney literature lists Dimopoulos among the leading contributors.
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.